CHMA
Chiasma

3,251
Loading...
Loading...
Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company's Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver. It is applicable to macromolecules that to-date can be administered only by injection. TPE can be utilized also with small molecules that are already orally available but are poorly absorbed.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Chiasma Inc?
What is the 52-week high for Chiasma Inc?
What is the 52-week low for Chiasma Inc?
What is Chiasma Inc stock price today?
What was Chiasma Inc stock price yesterday?
What is the PE ratio of Chiasma Inc?
What is the Price-to-Book ratio of Chiasma Inc?
What is the 50-day moving average of Chiasma Inc?

Latest CHMA News

View
No CHMA news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.